Ribociclib FDA label updated to include pre- and perimenopausal women©United States Food and Drug Agency

FDA approved avatrombopag for thrombocytopenia in CLD patients scheduled for a procedure

/1 Comment/in /by

 

You might also like
Trastuzumab-biosimilar Herzuma® FDA approved in HER2+ breast cancer
Ribociclib FDA label updated to include pre- and perimenopausal women©United States Food and Drug Agency Brentuximab vedotin FDA approved for pre-treated primary cutaneous anaplastic large cell lymphoma or CD30-expressing mycosis fungoides
Single-agent pembrolizumab FDA approved for the first-line treatment of stage III NSCLC with PD-L1 TPS ≥1%
Ribociclib FDA label updated to include pre- and perimenopausal women©United States Food and Drug Agency Vemurafenib FDA approved for treatment of Erdheim-Chester Disease with BRAF V600 mutation
Ribociclib FDA label updated to include pre- and perimenopausal women©United States Food and Drug Agency Ivosidenib FDA approved for relapsed or refractory acute myeloid leukemia
Ribociclib FDA label updated to include pre- and perimenopausal women©United States Food and Drug Agency Cabozantinib FDA approved for treatment of patients with advanced renal cell carcinoma
MediPr medipr.org medi-paper.com MediNews Asia MediNews.asia MediNews.cn MediPaper Medical Communications Ltd Healthcare Writers Medical Writers Medical Writer Agency Hong Kong Medical Writing Services Solutions Quote 醫學寫作 香港 醫學作家香港©United States Food and Drug Agency US FDA Duvelisib FDA approved for adult patients with R/R follicular lymphoma
Ribociclib FDA label updated to include pre- and perimenopausal women©United States Food and Drug Agency FDA approved pembrolizumab for chemotherapy-refractory r/m cervical cancer with PD-L1 CPS ≥1 
1 reply

Trackbacks & Pingbacks

  1. FDA approved avatrombopag for thrombocytopenia in CLD patient scheduled for a procedure - MediNews Asia says:
    23rd May 2018 at 11:47 PM

    […] post FDA approved avatrombopag for thrombocytopenia in CLD patient scheduled for a procedure appeared first on Medical Writer Agency | 香港醫學作家 | MediPR | MediPaper Hong […]

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply